Tombal, B.; Stenzl, A.; Cella, D.; Loriot, Y.; Armstrong, A.J.; Fizazi, K.; Beer, T.; Sternberg, C.N.; Hussain, M.; Ivanescu, C.;
et al. The Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials. Cancers 2021, 13, 5872.
https://doi.org/10.3390/cancers13235872
AMA Style
Tombal B, Stenzl A, Cella D, Loriot Y, Armstrong AJ, Fizazi K, Beer T, Sternberg CN, Hussain M, Ivanescu C,
et al. The Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials. Cancers. 2021; 13(23):5872.
https://doi.org/10.3390/cancers13235872
Chicago/Turabian Style
Tombal, Bertrand, Arnulf Stenzl, David Cella, Yohann Loriot, Andrew J. Armstrong, Karim Fizazi, Tomasz Beer, Cora N. Sternberg, Maha Hussain, Cristina Ivanescu,
and et al. 2021. "The Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials" Cancers 13, no. 23: 5872.
https://doi.org/10.3390/cancers13235872
APA Style
Tombal, B., Stenzl, A., Cella, D., Loriot, Y., Armstrong, A. J., Fizazi, K., Beer, T., Sternberg, C. N., Hussain, M., Ivanescu, C., Ganguli, A., Ramaswamy, K., & Saad, F.
(2021). The Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials. Cancers, 13(23), 5872.
https://doi.org/10.3390/cancers13235872
